Blockage of sphingosine-1-phosphate receptor 2 attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice
Open accessThe DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Sphingosine-1-phosphate (S1P) and its receptors have been implicated in functions of Langerhans cells and atopic dermatitis. In this study, we investigated the roles of S1P receptor type 2 (S1P 2) in a mouse model of atopic dermatitis, which was induced by topical application of 2,4-dinitrochlorobenzene (DNCB) on ventral skin on D0, followed by repeated DNCB challenge on both ears from D7 to D49. Wild-type mice with atopic dermatitis displayed severe inflammation and mast cell accumulation in ear tissues and elevated IgE levels in serum. Furthermore, the mice showed significantly increased sizes of draining lymph nodes, high levels of inflammatory cytokines (IL-4, IL-13, IL-17, and IFN-γ) in the ears and lymph nodes and high levels of chemokines CCL17 and CCL22 in ears. Administration of JTE-013, a selective antagonist of S1P 2 (3 mg/kg, i.p, from D19 to D49) before DNCB challenge significantly suppressed DNCB-induced atopic responses in ears and lymph nodes. JTE-013 administration also significantly decreased the lymph nodes sizes, the levels of inflammatory cytokines (IL-4, IL-13, IL-17, and IFN-γ) in the ears and lymph nodes, and the levels of chemokines CCL17 and CCL22 in ears. Furthermore, the inflammatory responses of atopic dermatitis were greatly ameliorated in S1pr2 gene-deficient mice. As CCL17 and CCL22 are CCR4 ligands, acting as Th2-attracting chemokines, we investigated CCL17 and CCL22 expression in bone marrow-derived dendritic cells (BMDCs) from wild-type and S1pr2 gene-deficient mice. Addition of IL-4 (10 ng/mL) markedly increased the levels of CCL17 and CCL22, but IL-4-induced CCL17 and CCL22 expression was significantly blunted in BMDCs from S1pr2 gene-deficient mice. Furthermore, pretreatment with JTE-013 (1-30 μM) dose-dependently suppressed this induction in BMDCs from wild-type mice. Our results demonstrate that blockage of S1P 2 ameliorates not only DNCB-induced atopic dermatitis symptoms but also Th2 cell-attracting capacity of dendritic cells, suggesting S1P 2 as a potential therapeutic target for atopic dermatitis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The topical application of the prototypical S1PR agonist fingolimod (mol. wt 343) has been reported to reduce allergic inflammation in animal models of skin disorders169–171.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [171]
Citations
Cites
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Lutz, M. B., Kukutsch, N., Ogilvie, A. L. J., Rößner, S., Koch, F., Romani, N., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00204-x · Cited by 2,966
Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis
Koga, C., Kabashima, K., Shiraishi, N., Kobayashi, M., & Tokura, Y. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.111 · Cited by 671
Cytokines and chemokines orchestrate atopic skin inflammation
Homey, B., Steinhoff, M., Ruzicka, T., & Leung, D. Y. M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.03.047 · Cited by 579
Muraro, A., Lemanske, R. F., Hellings, P. W., Akdis, C. A., Bieber, T., Casale, T. B., Jutel, M., Ong, P. Y., Poulsen, L. K., Schmid-Grendelmeier, P., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.03.010 · Cited by 284
Functions of the Multifaceted Family of Sphingosine Kinases and Some Close Relatives
Spiegel, S., & Milstien, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r600028200 · Cited by 219
Davidson, W. F., Leung, D. Y. M., Beck, L. A., Berin, C. M., Boguniewicz, M., Busse, W. W., Chatila, T. A., Geha, R. S., Gern, J. E., Guttman-Yassky, E., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.01.003 · Cited by 200
Deafness and Stria Vascularis Defects in S1P2 Receptor-null Mice
Kono, M., Belyantseva, I. A., Skoura, A., Frolenkov, G. I., Starost, M. F., Dreier, J. L., Lidington, D., Bolz, S.-S., Friedman, T. B., Hla, T., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700370200 · Cited by 191
Sawicka, E., Zuany-Amorim, C., Manlius, C., Trifilieff, A., Brinkmann, V., Kemeny, D. M., & Walker, C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6206 · Cited by 141
Sphingosine 1-Phosphate Receptor Modulators and Drug Discovery
Park, S.-J., & Im, D.-S. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.160 · Cited by 130
Self-citation
Cited by
Atopic dermatitis: an expanding therapeutic pipeline for a complex disease
Bieber, T. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00266-6 · Cited by 623
Sphingosine 1-Phosphate as Essential Signaling Molecule in Inflammatory Skin Diseases
Kleuser, B., & Bäumer, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021456 · Cited by 42
“All the more surprising are the studies in an animal model of AD, as the inflammatory response is significantly ameliorated in S1PR2-deficient mice [64,112].”
BackgroundSphingosine 1-Phosphate Signaling at the Skin Barrier Interface
Masuda‐Kuroki, K., & Nardo, A. D. (2022) · Biology · doi:10.3390/biology11060809 · Cited by 48
“[69] reported that, in a mouse model of atopic er titi , , l l li fl s IL-4, IL-13, IL-17, and IFN-γ in th ear and lymph nodes, and l vels of chemokines CCL17 and CCL22.”
BackgroundLin, Y., Chen, X., He, L., Yan, X., Li, Q., Zhang, X., He, M.-H., Chang, S., Tu, B., Long, Q., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115799 · Cited by 26
Wang, Y., Lu, H., Cheng, L., Guo, W., Hu, Y., Du, X., Liu, X., Xu, M., Liu, Y., Zhang, Y., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155856 · Cited by 28
Metadata
- Authors
- Park, S.-J., & Im, D.-S.
- Affiliations
- Pusan National University (KR)
- Kyung Hee University (KR)
- Corresponding author
- Im, Dong-Soon
- ORCID
- Im, Dong-Soon
- Venue
- Acta Pharmacologica Sinica
- Published
- 2020-05-26
- Volume
- 41
- Issue
- 11
- Pages
- 1487-1496
- ISSN
- 0253-9756 (ISSN-L)
- 1671-4083
- 1745-7254
- PMC
- PMC7656654
- OpenAlex
- W3032741072
- Cited by
- 34
- References
- 38
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 7 · 2023: 11 · 2022: 7 · 2021: 4
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Acta Pharmacologica Sinica (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Research Foundation
- Ministry of Education, Science and Technology (NRF-2019R1A2C1005523)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- atopic dermatitis, S1PR2, JTE-013, 1-chloro-2,4-dinitrobenzene, mast cell accumulation, IgE, inflammatory cytokines, CCL17, CCL22, CCR4, Th2 chemokines, dendritic cells, IL-4
- MeSH terms
- Sphingosine-1-Phosphate Receptors, Animals, Dermatitis, Atopic, Dinitrochlorobenzene, Ear, Lymph Nodes, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Pyrazoles, Pyridines, Mice, Knockout, Chemokine CCL17, Chemokine CCL22
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blockage of sphingosine-1-phosphate receptor 2 attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice. https://app.cochat.ai/papers/10.1038/s41401-020-0412-8
- The paper
- Park, S.-J., & Im, D.-S. (2020). Blockage of sphingosine-1-phosphate receptor 2 attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice. Acta Pharmacologica Sinica. https://doi.org/10.1038/s41401-020-0412-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.